OBJECTIVE: The study examined the effectiveness of amantadine in reducing cocaine withdrawal symptoms and improving treatment outcome among cocaine-dependent patients in outpatient treatment. METHOD: Sixty-one cocaine-dependent subjects participated in a double-blind, placebo-controlled trial of amantadine. RESULTS: Among subjects with severe cocaine withdrawal symptoms at the start of treatment, those who received amantadine used significantly less cocaine during the trial than did subjects who received placebo. Compared to subjects who received placebo, subjects who received amantadine submitted significantly more benzoylecgonine-negative urine samples and used cocaine on significantly fewer days during the trial. CONCLUSIONS:Amantadine may be an effective treatment for cocaine-dependent patients with severe cocaine withdrawal symptoms.
RCT Entities:
OBJECTIVE: The study examined the effectiveness of amantadine in reducing cocaine withdrawal symptoms and improving treatment outcome among cocaine-dependent patients in outpatient treatment. METHOD: Sixty-one cocaine-dependent subjects participated in a double-blind, placebo-controlled trial of amantadine. RESULTS: Among subjects with severe cocaine withdrawal symptoms at the start of treatment, those who received amantadine used significantly less cocaine during the trial than did subjects who received placebo. Compared to subjects who received placebo, subjects who received amantadine submitted significantly more benzoylecgonine-negative urine samples and used cocaine on significantly fewer days during the trial. CONCLUSIONS:Amantadine may be an effective treatment for cocaine-dependent patients with severe cocaine withdrawal symptoms.
Authors: M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas Journal: Pharmacol Rev Date: 2016-07 Impact factor: 25.468
Authors: Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney Journal: Neuropsychopharmacology Date: 2009-07-01 Impact factor: 7.853
Authors: Mauro Pettorruso; Giovanni Martinotti; Marco Di Nicola; Marco Onofrj; Massimo Di Giannantonio; Gianluigi Conte; Luigi Janiri Journal: Front Psychiatry Date: 2012-11-27 Impact factor: 4.157